CC

Crescent Capital BDC, Inc.

CCAPFinancial ServicesNASDAQ

Asset Management

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$47.4M
-43.2% YoY
Net Income
$34.5M
-53.1% YoY
Free Cash Flow
$49.7M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▲ RSI OversoldRSI 29.3, below 30, stock may be oversold
Oct 12▲ RSI OversoldRSI 23.9, below 30, stock may be oversold
About Crescent Capital BDC, Inc.

Crescent Capital BDC, Inc. is as a business development company is a private debt fund. Valued at $319.1M, CCAP is a small-cap name in its sector. It specializes in directly investing.

Where CCAP stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, CCAP finished 18.69% below its 150-day moving average ($10.70) and 21.97% below its 200-day moving average ($11.15). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CCAP overbought or oversold?

At the October 20, 2026 close, CCAP's RSI(14) was 29.3, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$319.1M
Fwd P/E6.16
EPS$-0.09
Beta0.62
52W Change-39.4%
Dividend Yield17.36%
ROE-0.5%
Analysis

On the balance sheet, CCAP has $15.6M in cash with $926.0M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $49.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -0.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $23.2M to $47.4M.

With a beta below 0.7, Crescent Capital BDC, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Crescent Capital BDC, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing CCAP's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Financial Services stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms